Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04916197
PHASE4

Effect of Postoperative Prolonged Sedation With Dexmedetomidine After Successful Reperfusion With EVT on Long-term Prognosis in Patients With AIS (PPDET)

Sponsor: Beijing Chao Yang Hospital

View on ClinicalTrials.gov

Summary

Dexmedetomidine can attenuate the activity of the sympathetic nervous system under stress response and improve ischemia-reperfusion injury. The investigators hypothesized that the prolonged sedation of dexmedetomidine after successful reperfusion of endovascular thrombectomy may improve the clinical outcome of acute ischemic stroke patients.

Official title: Effect of Postoperative Prolonged Sedation With Dexmedetomidine After Successful Reperfusion With Endovascular Thrombectomy on Long-term Prognosis in Patients With Acute Ischemic Stroke (PPDET)

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

368

Start Date

2024-03-01

Completion Date

2026-12

Last Updated

2023-12-20

Healthy Volunteers

No

Interventions

DRUG

Dexmedetomidine prolonged sedation

Dexmedetomidine for 24h after patients finished endovascular thrombectomy and returned to ICU.

DRUG

0.9% saline

An equal dose of 0.9% saline 24h after patients finished endovascular thrombectomy and returned to ICU.

Locations (1)

Beijing ChaoYang Hospital

Beijing, Beijing Municipality, China